Experts warn of need to monitor TB drugs for side effects: experts

01 Nov 2014

1

The availability of TB drugs in the open market is posing a peculiar health problem;  experts say many patients did not follow-up with the doctors once they were put on anti-TB medicines and hence side effects such as liver failure went unnoticed.

A patient suspected of spinal TB was put on anti-TB drugs and after being on medication for over six months, he went into a coma as the dosage was not monitored.

It was only when the patient was put on ventilator and shifted to another hospital for an emergency liver transplant that his condition improved.

According to hospital officials they had seen at least three such cases in the last one year.

They said patients developed jaundice or derangement of blood clotting systems and were in a critical state," according to Dr Abhideep Chaudhary, consultant, liver transplant at the hospital.

He added the only option to save them was to perform a liver transplant.

According to doctors, while the anti-TB treatment was life saving, it needed careful monitoring.

Latest articles

Musk ramps up SpaceX moon plans as Bezos accelerates Blue Origin in race against China

Musk ramps up SpaceX moon plans as Bezos accelerates Blue Origin in race against China

Indians can now travel to 56 destinations without prior visa as passport ranking improves

Indians can now travel to 56 destinations without prior visa as passport ranking improves

CEO says EU’s IRIS2 must match Starlink on price and performance

CEO says EU’s IRIS2 must match Starlink on price and performance

Applied Materials jumps 12% as AI chip demand drives strong revenue forecast

Applied Materials jumps 12% as AI chip demand drives strong revenue forecast

Opening the silos: India approves 3 million tonnes of wheat and product exports

Opening the silos: India approves 3 million tonnes of wheat and product exports

Capgemini beats 2025 revenue target as WNS acquisition boosts AI-driven growth

Capgemini beats 2025 revenue target as WNS acquisition boosts AI-driven growth

The deregulation “holy grail”: Trump EPA dismantles the legal bedrock of climate policy

The deregulation “holy grail”: Trump EPA dismantles the legal bedrock of climate policy

France-backed Eutelsat beats revenue estimates as Starlink rivalry intensifies

France-backed Eutelsat beats revenue estimates as Starlink rivalry intensifies

Germany’s Stark reportedly crosses €1 billion valuation after fresh funding round

Germany’s Stark reportedly crosses €1 billion valuation after fresh funding round